| Date | Time | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|
| 26/05/2022 | 14:30 to 16:10 | Chronic Lymphocytic Leukemia | 14:50 to 15:10 | Do BTKi + BCL2 inhibitors need a partner? | Speaker |
| 26/05/2022 | 14:30 to 16:10 | Chronic Lymphocytic Leukemia | 15:30 to 15:50 | The BTKi inhibitors that continue to “heat-up” the class | Speaker |
| 26/05/2022 | 14:30 to 16:10 | Chronic Lymphocytic Leukemia | 15:50 to 16:10 | The PI3K inhibitors: the not-so “new kid on the block?” | Speaker |
| 26/05/2022 | 16:30 to 18:40 | Chronic Lymphocytic Leukemia | 18:10 to 18:40 | Q&A | Discussant |